Skip to content
Governance Register

← US public companies

Agile Therapeutics INC

SEC CIK 1261249 · AGRX · last insider filing 2024-08-26

Directors (from insider filings)

NameCapacity as filedFilings
Barbari Sharon Surrey Director filed 2020 - 2024
Altomari Alfred Director · Chief Executive Oficer filed 2014 - 2024
Fischer Seth H.Z. Director filed 2016 - 2024
Hubbard John W Director filed 2014 - 2024
Carson Sandra Director filed 2020 - 2024
Torrente Josephine Director filed 2021 - 2024
Tursi James Patrick Director filed 2014 - 2022
Shetty Ajit Director filed 2016 - 2022
Mckee William Director filed 2014 - 2019
Lele Abhijeet J Director filed 2014 - 2019
Hong Karen Director filed 2014 - 2016
Schiff Andrew N Director filed 2014 - 2016
Elms Steve Director filed 2014 - 2016
Purcell Dennis J Director filed 2014 - 2016
Aisling Capital III LP Director filed 2014 - 2016
Aisling Capital Partners III LP Director filed 2014 - 2016
Aisling Capital Partners III LLC Director filed 2014 - 2016

Officers (from insider filings)

NameTitle as filedFilings
Gilmore Geoffrey General Counsel filed 2015 - 2024
Coiante Scott M VP and Chief Financial Officer filed 2014 - 2024
Korner Paul Sr. VP and CMO filed 2020 - 2024
Conway Robert G Sr. VP Manufacturing & Supply filed 2017 - 2024
Welsh Amy Chief Commercial Officer filed 2022 - 2024
Butch Jason Principal Accounting Officer filed 2021 - 2022
Reilly Dennis Chief Financial Officer filed 2019 - 2022
Garner Elizabeth Sr.VP & Chief Medical Officer filed 2014 - 2019
Selman Renee Chief Commercial Officer filed 2016 - 2018
Macfarlane Katie Chief Commercial Officer filed 2014 - 2016

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.